ArticleBlood cancer journal2026

CPX-351 (Liposomal Cytarabine and Daunorubicin) versus venetoclax plus hypomethylating agent therapy in newly diagnosed acute myeloid leukemia: a retrospective comparison involving 600 Mayo Clinic patients.

Saubia Fathima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.